Laparoscopic peritoneal lavage cytology and immunocytology in pancreatic and periampullary carcinoma  by Midwinter, M.J. et al.
207
Introduction
Exfoliation of cells from intra-abdominal tumours into the
peritoneal cavity has been recognised for many years. In
patients with ascites, the presence of malignant cells
recognised cytologically has been utilised for diagnostic
purposes. The recognition of tumour cells from a well-
differentiated carcinoma is difficult cytologically.
Peritoneal metastases are a common finding at the time of
diagnosis of many intra-abdominal malignancies and a
common site for recurrence after resection. Washing the
peritoneal cavity at the time of operation and examining
the fluid cytologically has been performed in a variety of
malignancies [1,2] including colorectal, stomach, biliary
and pancreatic cancers. Positive peritoneal cytology in pan-
creatic and periampullary cancer is associated with a grave
prognosis, with a median cumulative survival at 3 and 6
months of 17% and 8% compared with 87% and 71% in
patients with negative peritoneal cytology [3]. In pancreatic
carcinoma, most peritoneal cytology studies have been
performed by lavage at laparotomy, although it would obvi-
ously be desirable to obtain this staging information laparo-
scopically. A few studies examining laparoscopic peritoneal
lavage have been performed with conventional cytological
examination of the specimen [3].
Peritoneal metastases are present in 50% of patients
with pancreatic cancer at the time of death, and the
peritoneum is the second commonest site for metastases
after the liver [4]. Malignant cells have been identified in
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Background
Free tumour cells in the peritoneal cavity of patients with
pancreatic carcinoma carry a poor prognosis. Reactive or
degenerative mesothelial cells can make cytological inter-
pretation with conventional stains difficult. Detection of
the tumour-associated antigens carcinoembryonic antigen
(CEA) and CA19-9 may improve detection.
Methods
At staging laparoscopy, 22 patients with pancreatic or peri-
ampullary tumours had ascitic fluid aspirated or peritoneal
lavage performed. Both conventional and immunocytologi -
cally stained preparations were examined. Antibodies to
CEA and CA19-9 and the epithelial marker BerEP4 were
used. Lavage fluid from ten patients having operative treat-
ment for benign pancreatic or biliary conditions was also
examined.
Results
No malignant cells on conventional cytological criteria
were recovered. Thirteen of the 22 patients with pancre-
atic or periampullary carcinoma had peritoneal cells that
were positive for CEA and/or CA19-9. None was positive
for BerEP4. No patients with resectable disease had cells
that were positive for CEA or CA19-9 compared with 13
of 18 (72%) who had unresectable disease. One patient
(10%) with benign disease (chronic pancreatitis) had cells
recovered that were weakly positive for CEA but negative
for CA19-9 and BerEP4.
Discussion
Recovery of cells from the peritoneal cavity of patients
with pancreatic or periampullary carcinoma that are
expressing the tumour-associated antigens CEA or CA19-9
does not indicate the presence of free tumour cells but is
associated with advanced disease.
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peritoneal washings from 7% [5] to 30% [6] of pancreatic
cancer patients using conventional cytological stains.
Warshaw and colleagues [6] suggested that previous percu-
taneous fine needle aspiration (FNA) for cytology
increased the presence of free peritoneal tumour cells from
19% to 75%. This finding was not corroborated by Leach
and associates [5], who found no increase in positive peri-
toneal cytology following FNA. Both groups found the
presence of free peritoneal tumour cells to be a poor prog-
nostic sign. The presence of reactive and degenerative
mesothelial cells can hamper interpretation with conven-
tional cytological stains.
It has been suggested that immunocytology may
improve detection of scanty malignant cells in a peritoneal
lavage specimen. Using conventional cytological stains
plus immunocytological methods with antibodies to carci-
noembryonic antigen (CEA) and the tumour-associated
antigen CA19-9, Nomoto and co-workers [7] found some
antibody-positive cells that were not recognised as malig-
nant by conventional cytological criteria. These cells were
not characterised further. In another immunocytological
study, Juhl and colleagues [8 ] found some peritoneal cells
positive for CA19-9 but negative to the epithelial
membrane antigen C-54-0. None of these studies has
examined a group of patients with benign pancreatic or
biliary conditions.
The aim of this study was to examine cells recovered by
laparoscopic peritoneal lavage in pancreatic and peri-
ampullary cancer patients and in those with benign
pancreaticobiliary disease, using conventional cytological
stains and immunocytochemical staining for the tumour-
associated antigens CEA and CA19-9 and for the epithelial
marker BerEP4.
Patients and methods
Consecutive patients presenting to the unit with pancreatic
or periampullary adenocarcinoma were assessed by pre-
operative triple phase contrast-enhanced spiral computed
tomography, gadolinium-enhanced magnetic resonance
imaging and endoscopic ultrasound. Twenty-two patients
had no evidence by these modalities of metastases or locally
advanced disease involving the superior mesenteric vessels
or portal vein and entered the study. Ten patients with
benign pancreaticobiliary pathology also had peritoneal
lavage performed. Lavage was performed at staging
laparoscopy in the patients with carcinoma. None of the
patients had had prior FNA. Pneumoperitomeum was
induced and intra-abdominal pressure was set at 10 mmHg.
An 11 mm trocar was used at the umbilicus and a 12 mm
trocar was introduced under direct vision in the left upper
quadrant of the abdomen. Any ascitic fluid was aspirated
and sent as the specimen. If no ascitic fluid was found, peri-
toneal lavage was performed. Before any manipulation of
the tissues, 50 ml 0.9% saline was introduced into the
abdomen by a suction/irrigation cannula, irrigating over
the greater omentum and around the right upper quadrant.
The patient was gently agitated on the operating table for
several minutes and the fluid was aspirated into two 20 ml
universal containers. After peritoneal lavage a full
laparoscopic assessment was performed, including evalua-
tion with laparoscopic ultrasound. For patients with benign
disease having a laparotomy, the irrigation was performed
as soon as the peritoneal cavity was open and before any
manipulation.
The specimens were processed immediately. The entire
specimen was centrifuged at 1500 rpm for 5 min, then the
supernatant decanted and the cell pellet re-suspended.
Smear and cytospin preparations were made from the
suspension.
Conventional cytological stains consisted of
Papanicolau (PAP), May-Grunwald and Giesma
(MGG), Periodic Acid Schiff (PAS) and Diastase
Periodic Acid Schiff (DPAS). Slides for PAP staining
were fixed in 95% ethyl alcohol immediately on prepa-
ration. Slides for MGG, PAS and DPAS were air-dried
before fixation.
Immunocytology was performed using monoclonal
mouse anti-human CEA and CA19-9 (Novocastra
Laboratories Ltd, Newcastle upon Tyne, UK) and mouse
anti-human BerEP4 (DAKO, Glostrup, Denmark). The
BerEP4 antigen is expressed by normal and neoplastic
epithelium (including pancreatic carcinoma) but not by
mesothelium [9]. Antigen unmasking with microwave
irradiation (700 W for 5 min, repeated once) was used for
the CA19-9 slides. A biotin/avidin immunoperoxidase
(Vectastain, Vector Laboratories, Peterborough, UK) and
diaminobenzadine with 0.01% hydrogen peroxide substrate
(DAB) system was used to identify bound antibody.
Positive control paraffin sections of colonic
adenocarcinoma (known to express CEA, CA19-9 and
BerEP4) were stained at the same time that immunocyto-
logical preparations were made from the lavage specimens.
Counterstaining with haematoxylin was performed.
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The conventionally stained cytological preparations
were all examined by a single consultant cytopathologist
(VW). The appropriate clinical information was available
as is normal practice. Immunocytological interpretation
was performed by two observers blinded to the results
of the conventional cytology (MJM and AW). A positive
immunocytological result was defined as any positive stain-
ing cell other than a polymorphonuclear leucocyte.
The findings of metastases were all confirmed histolog-
ically, and the vascular involvement was confirmed by sur-
gical assessment at laparotomy.
Results
All peritoneal lavage specimens were BerEP4 negative. The
control paraffin sections of colonic adenocarcinoma were
positive to BerEP4, CEA and CA19-9.
Of the ten patients with benign pathology, three were
undergoing procedures for chronic pancreatitis and seven
for cholelithiasis. One of these lavage specimens was acel-
lular. None showed abnormal cells on conventional cytol-
ogy. One patient with chronic pancreatitis had cells that
showed weak positivity for CEA. The remainder showed no
positivity for CA19-9 or CEA.
Ascitic fluid was found in five of the 22 patients with
pancreatic or periampullary carcinoma. No malignant cells
were identified using conventional cytological stains from
either ascitic fluid or peritoneal lavage in the pancreatic
cancer patients. No cells were recovered that were positive
for BerEP4. Thirteen patients had cells recovered from the
peritoneum that were positive for CA19-9 or CEA (Table
1). Four patients showed positivity for CA19-9 alone, eight
for CEA alone, and one was positive to both CA19-9 and
CEA. Three of the five patients with ascitic fluid had
immuncytologically positive cells (1 CEA, 1 CA19-9, 1
both antigens).
Four of the patients with pancreatic or periampullary
cancer had a resection. All of these were considered cura-
tive with no evidence of microscopic residual disease at the
resection margins. Three had peripancreatic lymph nodes
involved but none had known lymph node metastases out-
side this area. The distribution of metastases or areas of
locally advanced disease that precluded the patient from a
resection is shown in Table 1. None of the four patients
having tumour resection had cells on peritoneal lavage that
were positive for either CA19-9 or CEA. Nine of 14 (64%)
patients with metastatic disease and all patients with
locally advanced disease and vascular infiltration had cells
recovered from the peritoneum that were positive for
CA19-9 or CEA. The finding of cells from peritoneal
lavage that were positive for either CEA or CA 19-9 was
significantly associated with unresectability (Fisher’s exact
test, p<0.05).
In all cases in which CA19-9 or CEA was expressed, the
antigens were found both around the cell membrane and
within the cytoplasm (Figure 1).
Discussion
Improvement in the preoperative staging of pancreatic and
periampullary carcinoma should mean fewer patients being
subjected to a laparotomy without a realistic expectation of
resection. Laparoscopy before laparotomy is the only reli-
able means of examining for the presence of peritoneal
metastases. In the absence of peritoneal deposits, ascitic
fluid or peritoneal lavage fluid can be examined. Detecting
scanty malignant cells amongst reactive and degenerative
mesothelial cells can be difficult. It has been suggested that
immunocytology may improve the detection of malignant
cells [3].
There are theoretical reasons why the antigens CEA and
CA19-9 may be of interest. They are frequently expressed
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Table 1. Peritoneal immunocytology in pancreatic and periampullary cancer
Clinical findings No. CA19-9 No. CEA Proportion of patients with
(No. of patients) positive positive positive immunocytology
Liver metastases (8) 2 4 5/8
Peritoneal metastases(2) 1 0 1/2
LN metastases* (4) 0 3 3/4 
Vascular infiltration (4) 2 2 4/4
Resected (4) 0 0 0/4
*Lymph node metastases outside field of surgical resection
in pancreatic and periampullary carcinomas and have func-
tions as adhesion molecules. Sialyl Lewisa (sLea) is the
immune determinant of the tumour-associated antigen
CA 19-9 and is the ligand of E-selectin, a member of the
selectin family of adhesion molecules. The selectin family
of molecules have been implicated in the extravasation of
neutrophils in acute inflammation [10]. Attachment of
tumour cells from pancreatic cancer cell lines to
endothelium has been associated with sLea in vitro [11]. It
has been suggested that sLea is an important mediator of
haematogenous metastasis in pancreatic cancer [12].
Carcinoembryonic antigen is a member of the immuno-
globulin supergene family of adhesion molecules.
Paradoxically, CEA seems to have both cell adhesion and
cell contact inhibitory properties [13]. CEA has also been
shown to act as an accessory adhesion molecule in colon
epithelial cell-collagen interactions, and the staining pat-
tern has been shown to be predictive of malignant poten-
tial in colorectal cancer [14]. The immunocytochemical
staining pattern in the pancreas for each antigen changes
from being localised to the luminal surface of the normal
epithelium to the basolateral membrane and cytoplasmic
expression in hyperplasia and over the entire cell surface,
cytoplasm and stroma in neoplasia [15]. Similar changes in
CEA localisation have been noted in colonic and gastric
cancers [16]. The finding of sialyl-rich tumour-associated
antigens in the stroma of gastric cancer has been associated
with peritoneal metastases [17]. The presence of these mol-
ecules in the tumour stroma could saturate the receptors,
leading to less cell–cell and cell–endothelium adhesion.
When they reach an environment in which saturation of
the adhesion molecules no longer pertains, cell–cell and
cell–endothelium adhesion could take place. This process
could then allow the formation of a metastatic deposit.
No malignant cells on conventional cytological stain-
ing were recovered from peritoneal lavage of patients with
pancreatic or periampullary carcinoma in this study. This
finding is at variance with the published rate of 7–30%.
Taking the lower incidence, one would have expected two
patients to have positive peritoneal cytology. The absence
of malignant cells on conventional cytology could be due to
detailed preoperative staging with spiral CT, MRI and
endoscopic ultrasound before selecting patients for
laparoscopy. These patients had potentially resectable dis-
ease from their staging investigations and would therefore
tend to have less disease burden than in older series where
the preoperative investigation was less exacting. In addi-
tion, no patients had prior FNA or biopsy. In the study of
John and associates [3], they found positive peritoneal
cytology on conventional staining in seven of 46 patients,
three of whom had had prior percutaneous needle aspira-
tion or biopsy. Laparoscopic ultrasound was used as part of
our staging assessment, and it demonstrated lymph node
and hepatic metastases (with histological confirmation)
that were not detected by the other staging modalities. This
fact explains the low resectability rate in the series despite
the extensive preoperative imaging.
In this study, non-epithelial cells expressing the mole-
cules CA19-9 (sLea) and CEA have been recovered from
the peritoneal cavity of patients with pancreatic carci-
noma. Cells recovered from peritoneal lavage in patients
with benign disease did not express these antigens with the
exception of one patient with chronic pancreatitis who had
some weakly CEA positive cells. The presence of cells
expressing these antigens in pancreatic and periampullary
carcinoma patients was significantly associated with irre-
sectable disease by virtue of local advancement or second-
ary spread. The absence of cells expressing CA19-9 or CEA
was associated with resectable disease. The presence of
these antigens may represent uptake of free CA19-9 and
free CEA in the peritoneal cavity by mesothelial cells and
reflect the disordered expression of these antigens in the
primary tumour. Caution is therefore required in the inter-
pretation of positively staining cells for CEA or CA19-9;
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Figure 1. Cells recovered from a patient with pancreatic carcinoma by
peritoneal lavage staining positively for CA19-9 (positively staining cells are
brown).
they do not necessarily represent free tumour cells as they
are non-epithelial (BerEP4 negative). The usefulness of
automated techniques examining cells on the basis of their
immunoreactivity by, for example, flow cytometry is there-
fore limited. The relationship of immunopositivity of peri-
toneal cells and irresectability of the tumour may be an
epiphenomenon related to the disordered expression of
these antigens in the primary tumour and their adhesion
properties as outlined above.
The presence of cells from peritoneal lavage expressing
the tumour-associated antigens CA19-9 and CEA does not
indicate the presence of free tumour cells but is associated
with tumour irresectablity.
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